Steve is currently the Vice President and General Manager for AbbVie UK. AbbVie UK has 3 sites, employs over 1,000 employees, which manufacture, develop and commercialise innovative medicines in several key therapeutic areas including immunology, oncology, neuroscience, and eye care and aesthetics.

Steve has worked for AbbVie for the last 10 years starting in the UK as Business Unit Director, before being promoted and moving to Chicago as the Global General Manager for Atopic Dermatitis and prior to his current role, working in Paris as the Head of Commercial for Europe. Prior to AbbVie, Steve worked for Otsuka and Lundbeck in UK and International commercial roles of increasing importance.

In his current role, Steve is accountable for driving opportunities for the future acceleration of the UK AbbVie pharmaceutical business. He currently serves on the ABPI board and sits on the Innovation Committee, where he focuses on the strategic factors related to the pharmaceutical industry.

Steve earned a Bachelor of Science Degree in Biology and Sports Medicine from the University of Chester, England.